Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future

被引:7
|
作者
Shapiro, Michael D. [1 ]
Fazio, Sergio [2 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Ctr Prevent Cardiovasc Dis,Sect Cardiovasc Med, Winston Salem, NC 27103 USA
[2] Oregon Hlth & Sci Univ, Dept Med, Knight Cardiovasc Inst, Ctr Prevent Cardiol, Portland, OR 97201 USA
来源
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2020年 / 1卷
关键词
Preventive cardiology; Atherosclerotic cardiovascular disease (ASCVD); Dyslipidemia; Hypertension; Diabetes; Statins; PCSK9; inhibitors; Lipid-lowering agents; CVD risk assessment; Lipid clinic; Cardio-metabolic medicine; HEART-DISEASE MORTALITY; PCSK9; INHIBITORS; RISK; FRAMINGHAM; CARE;
D O I
10.1016/j.ajpc.2020.100011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology
    Wong, Nathan D.
    Toth, Peter P.
    Amsterdam, Ezra A.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 49 - 56
  • [2] The Role of the Clinical Pharmacist in a Preventive Cardiology Practice
    Warden, Bruce A.
    Shapiro, Michael D.
    Fazio, Sergio
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (12) : 1214 - 1219
  • [3] The future of education in Preventive Cardiology: a statement of the European Association of Preventive Cardiology of the European Society of Cardiology
    Koskinas, Konstantinos C.
    Wilhelm, Matthias
    Halle, Martin
    Biffi, Alessandro
    Cavarretta, Elena
    Davos, Constantinos H.
    Frederix, Ines
    Gaber, Marwa Hemmat
    Hansen, Dominique
    Jones, Jennifer L.
    Malhotra, Aneil
    Papadakis, Michael
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (16) : 1904 - 1911
  • [4] Valsartan: the past, present and future
    Kober, Lars
    Torp-Pedersen, Christian
    FUTURE CARDIOLOGY, 2005, 1 (05) : 591 - 598
  • [5] Sports cardiology: A glorious past, a well-defined present, a bright future
    D'Ascenzi, Flavio
    Ragazzoni, Gian L.
    Boncompagni, Alex
    Cavigli, Luna
    CLINICAL CARDIOLOGY, 2023, 46 (09) : 1015 - 1020
  • [6] PCSK9 inhibitors - past, present and future
    Reiner, Zeljko
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1517 - 1521
  • [7] The past, present and future of lipid-lowering therapy
    Najam, Osman
    Lambert, Gilles
    Ray, Kausik K.
    CLINICAL LIPIDOLOGY, 2015, 10 (06) : 481 - 498
  • [8] Cancer research: past, present and future
    Cao, Ya
    DePinho, Ronald A.
    Ernst, Matthias
    Vousden, Karen
    NATURE REVIEWS CANCER, 2011, 11 (10) : 749 - 754
  • [9] Ferroptosis inhibitors: past, present and future
    Zhang, Lei
    Luo, Yi Lin
    Xiang, Yang
    Bai, Xin Yue
    Qiang, Rong Rong
    Zhang, Xin
    Yang, Yan Ling
    Liu, Xiao Long
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Aging and Medications: Past, Present, Future
    Schwartz, J. B.
    Abernethy, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (01) : 3 - 10